15. Mai 2025Oveporexton, an Oral Orexin Receptor 2– Selective Agonist, in Narcolepsy Type 1
5. Mai 2026Insights from a randomized controlled trial on a digital lifestyle intervention in non-small cell lung cancer survivors following inpatient rehabilitation
